Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis

BACKGROUND: Cholinesterase inhibitors (ChEIs) are the only drugs marketed for the treatment of Alzheimer's disease. Despite numerous randomized controlled trials, the efficacy and safety of this group of medications has not been quantified. Our objective was to quantitatively summarize data on...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lanctôt, Krista L., Herrmann, Nathan, Yau, Kenneth K., Khan, Lyla R., Liu, Barbara A., LouLou, Maysoon M., Einarson, Thomas R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2003
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC191283/
https://ncbi.nlm.nih.gov/pubmed/12975222
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak